DiaGenic

For earlier disease detection

Image related to: DiaGenicDiaGenic

The world’s first blood based gene expression tests for breast cancer and Alzheimer’s

DiaGenic is a Norwegian life science company listed on the Oslo Stock Exchange. DiaGenic is a world in leader in blood gene expression profiling with a pioneering and strong intellectual property position. Based on this unique approach DiaGenic is now launching it’s two first products for early detection of breast cancer and Alzheimer’s disease. In its development portfolio there are two other eagerly awaited tests, one for early detection of Parkinson’s disease and a biomarker for MCI (Mild Cognitive Impairment).

Image related to: DiaGenicDiaGenic